ProShare Advisors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

ProShare Advisors’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-884	Closed	-$58K	–	2433
2021 Q1	$58K	Buy	884 +457	+107%	+$31.9K	﹤0.01%	2217
2020 Q4	$28K	Buy	+427	New	+$27.8K	﹤0.01%	2080
2015 Q2	–	Sell	-365	Closed	-$54K	–	1812
2015 Q1	$54K	Sell	365 -32	-8%	-$4.87K	﹤0.01%	1864
2014 Q4	$62K	Sell	397 -344	-46%	-$49.5K	﹤0.01%	1900
2014 Q3	$106K	Sell	741 -168	-18%	-$24.4K	﹤0.01%	2152
2014 Q2	$119K	Sell	909 -988	-52%	-$125K	﹤0.01%	2321
2014 Q1	$232K	Buy	+1,897	New	+$206K	﹤0.01%	2417
2013 Q4	–	Sell	-1,191	Closed	-$134K	–	2004
2013 Q3	$134K	Sell	1,191 -11	-0.9%	-$1.25K	﹤0.01%	2335
2013 Q2	$136K	Buy	+1,202	New	+$147K	﹤0.01%	2161

Other funds holding SRGA

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

TownSquare Capital Provo, Utah $444M AUM 24.03% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

ProShare Advisors's SRGA Position: Q2 2021 in Review

ProShare Advisors sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 884 shares — an estimated $58K sold.

ProShare Advisors first reported a position in SRGA in Q2 2013 and held it in 9 quarters. The position peaked at $232K in Q1 2014. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.

ProShare Advisors reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
ProShare Advisors sold 884 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $58K.
ProShare Advisors first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 9 quarters.
ProShare Advisors's Surgalign Holdings, Inc. Common Stock position peaked at $232K in Q1 2014.
89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.